TY - JOUR T1 - Spatial versus angular resolution for tractography-assisted planning of deep brain stimulation JF - medRxiv DO - 10.1101/19008813 SP - 19008813 AU - Luka C. Liebrand AU - Guido A. van Wingen AU - Frans M. Vos AU - Damiaan Denys AU - Matthan W.A. Caan Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/10/22/19008813.abstract N2 - Given the restricted total scanning time for clinical neuroimaging, it is unclear whether clinical diffusion MRI protocols would benefit more from higher spatial resolution or higher angular resolution. In this work, we investigated the relative benefit of improving spatial or angular resolution in diffusion MRI to separate two parallel running white matter tracts that are targets for deep brain stimulation: the anterior thalamic radiation and the supero-lateral branch of the medial forebrain bundle. Both these tracts are situated in the ventral anterior limb of the internal capsule, and recent studies suggest that targeting a specific tract could improve treatment efficacy. Therefore, we scanned 19 healthy volunteers at 3T and 7T according to three diffusion MRI protocols with respectively standard clinical settings, increased spatial resolution of 1.4 mm, and increased angular resolution (64 additional gradient directions at b=2200s/mm2). We performed probabilistic tractography for all protocols and quantified the separability of both tracts. The higher spatial resolution protocol improved separability by 41% with respect to the clinical standard, presumably due to decreased partial voluming. The higher angular resolution protocol resulted in increased apparent tract volumes and overlap, which is disadvantageous for application in precise treatment planning. We thus recommend to increase the spatial resolution for deep brain stimulation planning to 1.4 mm while maintaining angular resolution. This recommendation complements the general advice to aim for high angular resolution to resolve crossing fibers, confirming that the specific application and anatomical considerations are leading in clinical diffusion MRI protocol optimization.Competing Interest StatementM.W.A. Caan is stock owner of Nico-lab B.V. The other authors declare no competing financial interests.Funding StatementThis study was supported by an Innovation Impulse grant (#2015.011) from the Academic Medical Center. Additionally, the study was financially supported as part of the STW Perspectief programme Population Imaging Genetics (ImaGene) by the Dutch Technology Foundation (STW), project 12722.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableWe are not allowed to share data online, since complete anonymization is impossible and the data can be traced back to individual participants. ER -